Current Intelligence Bulletin 12 – Diethylcarbamoyl Chloride (DECC)
Public Domain
-
1976/07/07
-
Series: NIOSH Numbered Publications
Details
-
Corporate Authors:
-
Description:This Current Intelligence Bulletin (CIB) briefly presents information on the genotoxic hazards associated with diethylcarbamoyl-chloride (88108) (DECC). A study of the mutagenic potential of DECC found that it was mutagenic in two strains of Escherichia-coli, (WP-2) and (WP-2S). DECC, however, was not as potent a mutagen as the closely related analog dimethylcarbamoyl- chloride (79447) (DMCC). DMCC was found to have carcinogenic activity in laboratory animals after subcutaneous, intraperitoneal, and inhalation exposure, as noted in another NIOSH CIB. Annual production of DECC in recent years amounted to less than 15000 pounds. The only known commercial use of DECC in the United States was as an intermediate in the synthesis of diethylcarbamazine- citrate, a pharmaceutical used as an anthelmintic (worming agent). Diethylcarbamazine-citrate is said to be produced and marketed as Hetrazan and Caricide by Lederle Laboratories, a division of the American Cyanamide Company. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
Series:
-
Subseries:
-
DOI:
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:1
-
NIOSHTIC Number:nn:00170793
-
Citation:Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 78-127, (CIB 12), 1976 Jul; :1
-
CAS Registry Number:
-
Federal Fiscal Year:1976
-
Peer Reviewed:False
-
Source Full Name:National Institute for Occupational Safety and Health
-
Collection(s):
-
Main Document Checksum:urn:sha-512:dd69ecbc0c39dae40fe2cbc258bd9fa554e2c03ff90dad36a9d7bad7d02a8e3c55a6418ffce9fdbb9f0a54cb6f980b9c745e34523fa65a746da57fed0f10ab03
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like